All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Five experimental bispyridinium oximes in comparison with the conventional oximes pralidoxime and obidoxime: in vivo efficacy to protect from azinphos-methyl-induced toxicity

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60162694%3AG44__%2F13%3A43874862" target="_blank" >RIV/60162694:G44__/13:43874862 - isvavai.cz</a>

  • Result on the web

    <a href="http://www.stmconnect.com/sites/default/files/44-50%20%20JEIT-D-12-00009.pdf" target="_blank" >http://www.stmconnect.com/sites/default/files/44-50%20%20JEIT-D-12-00009.pdf</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.7178/jeit.14" target="_blank" >10.7178/jeit.14</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Five experimental bispyridinium oximes in comparison with the conventional oximes pralidoxime and obidoxime: in vivo efficacy to protect from azinphos-methyl-induced toxicity

  • Original language description

    In search of more efficacious treatment options for organophosphate poisoning, several experimental K-oximes have been synthesized, which display excellent in vitro efficacy in protecting acetylcholinesterase from inhibition by a broad variety of organophosphorus compounds. To test the efficacy of these K-oximes (K-27, K-48, K-53, K-74, K-75) in vivo, the extent of oxime-conferred protection from mortality induced by the organophosphate pesticide azinphos-methyl was quantified by Cox survival analysis and compared with that of the clinically available oximes pralidoxime and obidoxime. Rats received azinphos-methyl, which is hepatically converted to the active oxon form, in a dosage of 5, 10 or 15 mýmol, and immediately thereafter intraperitoneal injections of the respective oxime at a dosage of half the LD01. K-53 reduced the relative risk of death (RR) to 0.22 (controls: RR=1; pLESS-THAN OR EQUAL TO0.05), which was significantly (pLESS-THAN OR EQUAL TO0.05) better than obidoxime (RR=0

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    KA - Militarism

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2013

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Environmental Immunology and Toxicology

  • ISSN

    2225-1219

  • e-ISSN

  • Volume of the periodical

    1

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    7

  • Pages from-to

    44-50

  • UT code for WoS article

  • EID of the result in the Scopus database